CVS Health Corporation Stock Price Prediction 2026, 2027, 2030, 2040, 2050
CVS Health Corporation is a large healthcare company in the United States. It provides medicines, pharmacy services, health insurance, and other healthcare services. Its main businesses are its Pharmacy, Aetna health insurance, and CVS Caremark, which helps manage prescription drug plans. The company also provides primary care, medical clinics, speciality pharmacy services, and other health services. It serves millions of people across the U.S. through its pharmacies, clinics, insurance plans, and healthcare programs. It works with individuals, employers, health plans, and government healthcare programs to provide different healthcare services.
What is CVS Health Corporation NYSE: CVS?
CVS Health Corporation was founded in 1963 in Lowell, Massachusetts, by Stanley P. Goldstein, Sidney Goldstein, and Ralph P. Hoagland. Today, it is a large American healthcare company that provides pharmacy, health insurance, medicines, and healthcare services. It has CVS Pharmacy, Aetna, which provides health insurance, and CVS Caremark, which manages prescription drug plans. The company also provides basic medical care, health checkups, vaccinations, speciality pharmacy services, and other healthcare programs. It serves millions of people across the United States and works with individuals, employers, insurance companies, and government healthcare programs.
CVS Health Corporation Stock Price
CVS Health Corporation Stock Price Prediction 2026
It first sold health and beauty products. After one year, it changed its name. In 1967, it started adding pharmacies to its stores. This helped the company move further into the healthcare business. Over the years, it opened more stores and bought other pharmacy companies to grow its business. Later, it started offering more than just pharmacy services. It added healthcare clinics, prescription medicine services, and health insurance. In 2026, its stock price would be $142, as per stock market analysts.
According to stock market analysts, its stock price would be between $68 to $142 in 2026.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2026 | $68 | $142 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $69 | $82 |
| February | $71 | $78 |
| March | $68 | $80 |
| April | $70 | $83 |
| May | $79 | $97 |
| June | $88 | $105 |
| July | $101 | $110 |
| August | $92 | $105 |
| September | $80 | $101 |
| October | $76 | $118 |
| November | $88 | $135 |
| December | $100 | $142 |
CVS Health Corporation Stock Price Target 2027
Its Pharmacy is one of the main businesses. It provides prescription medicines, health products, and other everyday healthcare items to people across the United States. It has also added several ways for customers to get their medicines. It also offers services such as vaccinations and other basic healthcare support. These services make it easier for customers to get medicines and other health products. It serves millions of people and stays closely connected with its customers. In 2027, its stock price would be $213, as per stock market analysts.
According to stock market analysts, its stock price would be between $135 to $213 in 2027.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2027 | $135 | $213 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $135 | $160 |
| February | $138 | $168 |
| March | $142 | $172 |
| April | $144 | $177 |
| May | $149 | $183 |
| June | $154 | $185 |
| July | $160 | $189 |
| August | $163 | $195 |
| September | $167 | $200 |
| October | $170 | $204 |
| November | $179 | $209 |
| December | $185 | $213 |
Stock Price Prediction 2028
It also provides health insurance plans to individuals, employers, and other organisations. It offers different types of health plans, including business health insurance, Medicare, Medicaid, and other healthcare programs. Through Aetna, it helps people manage the cost of their medical care. This means the company is involved in both medicines and health insurance. Aetna also works with other businesses to connect insurance, pharmacy, and healthcare services. In 2028, its stock price would be $274, as per stock market analysts.
According to stock market analysts, its stock price would be between $200 to $274 in 2028.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2028 | $200 | $274 |
Stock Price Prediction 2029
It provides healthcare services through its stores, homes, and online platforms. These services help people with different health needs. The company provides medical care, support for managing health problems, mental health services, wellness programs, and other healthcare services. It has also expanded its healthcare business through companies such as Signify Health and Oak Street Health. In 2029, its stock price would be $331, as per stock market analysts.
According to stock market analysts, its stock price would be between $250 to $331 in 2029.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2029 | $250 | $331 |
CVS Health Corporation Stock Price Prediction 2030
It has also expanded its primary care business through Oak Street Health. The company provides primary care mainly to older adults. Primary care includes regular checkups, basic treatment, and help with managing health problems. It also provides care through clinics and other healthcare services. This allows the company to be involved in healthcare beyond selling medicines. Iti wants to connect its different services so people can get more complete care. In 2030, its stock price would be $406, as per stock market analysts.
According to stock market analysts, its stock price would be between $320 to $406 in 2030.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2030 | $320 | $406 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $320 | $351 |
| February | $324 | $355 |
| March | $327 | $362 |
| April | $332 | $366 |
| May | $335 | $368 |
| June | $341 | $372 |
| July | $347 | $376 |
| August | $350 | $382 |
| September | $357 | $385 |
| October | $359 | $393 |
| November | $365 | $400 |
| December | $378 | $406 |
Stock Price Prediction 2040
It also provides speciality pharmacy services for people who need complex medicines. These medicines are often used to treat serious or long-term health problems and may need special care. It helps patients get these medicines and provides support for managing their treatment. Speciality pharmacy services are available along with regular CVS pharmacies and mail-order services. The company also works with its other healthcare businesses to improve access to medicines and help manage their costs. In 2040, its stock price would be $1025, as per stock market analysts.
According to stock market analysts, its stock price would be between $888 to $1025 in 2040.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2040 | $888 | $1025 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $888 | $930 |
| February | $897 | $942 |
| March | $905 | $950 |
| April | $915 | $958 |
| May | $919 | $966 |
| June | $927 | $978 |
| July | $935 | $982 |
| August | $945 | $988 |
| September | $948 | $995 |
| October | $955 | $1004 |
| November | $962 | $1011 |
| December | $970 | $1025 |
Stock Price Prediction 2050
The company divides its business into three main areas: Health Care Benefits, Health Services, and Pharmacy and Consumer Wellness. Health Care Benefits mainly operates through Aetna and provides health insurance and related services. Health Services includes CVS Caremark, which manages prescription drug plans, along with other healthcare services. Pharmacy and Consumer Wellness includes CVS Pharmacy’s prescription services, vaccinations, health products, and other pharmacy services. In 2050, its stock price would be $1700, as per stock market analysts.
According to stock market analysts, its stock price would be between $1571 to $1700 in 2050.
| Year | Minimum Price ($) | Maximum Price ($) |
| 2050 | $1571 | $1700 |
| Month | Minimum Price ($) | Maximum Price ($) |
| January | $1571 | $1612 |
| February | $1580 | $1620 |
| March | $1584 | $1627 |
| April | $1590 | $1635 |
| May | $1600 | $1645 |
| June | $1604 | $1648 |
| July | $1610 | $1655 |
| August | $1617 | $1662 |
| September | $1620 | $1675 |
| October | $1627 | $1684 |
| November | $1632 | $1690 |
| December | $1640 | $1700 |
Should I buy CVS Health Corporation stock?
| Year | Minimum Price ($) | Maximum Price ($) |
| 2026 | $68 | $142 |
| 2027 | $135 | $213 |
| 2028 | $200 | $274 |
| 2029 | $250 | $331 |
| 2030 | $320 | $406 |
| 2040 | $888 | $1025 |
| 2050 | $1571 | $1700 |
It has shown improvement in its business in 2026, with better sales and earnings than the previous year. The company also expects its business to continue improving. Having different businesses helps the company earn money from different parts of the healthcare industry. But it also faces some risks, such as higher healthcare costs, pressure on pharmacy profits, changes in government healthcare programs, and new regulations. Its insurance business can also be affected when medical costs rise. Overall, it has some positive signs, but investors should carefully consider both its growth opportunities and the risks before investing.
CVS Health Corporation Financials
| Financial Year | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
| Total Revenue | 94.58 | 98.91 | 102.87 | 105.69 | 100.42 | 106.09 |
| Gross Profit | 14.39 | 13.59 | 13.80 | 13.56 | 15.62 | 15.74 |
| Net Income | 1.77 | 1.02 | -3.97 | 2.94 | 2.94 | 2.99 |
| Net Profit Margin | 1.88% | 1.03% | -3.86% | 2.78% | 2.93% | 2.82% |
Key Metrics
| PE TTM | PB | EPS TTM | PEG Ratio | Profit Margin | Dividend Yield |
| 24.92 | 1.51 | $3.68 | 0.22 | 1.18% | 2.82% |
Peers & Comparison
| Stock | PE TTM | PB | PEG Ratio |
| CVS Health Corp | 24.92 | 1.51 | 0.22 |
| Cigna Corp | 11.94 | 1.79 | 0.78 |
| Quest Diagnostics Incorporated | 26.25 | 3.62 | 1.91 |
Is CVS Health Corporation stock good to buy? (bull case & bear case)
Bull Case:
- It made $106.1 billion in revenue in Q2 2026, compared with $98.9 billion in Q2 2025.
- Its net income rose to $3.0 billion in Q2 2026 from $1.0 billion in Q2 2025.
- Adjusted earnings per share increased to $2.58 from $1.81 a year earlier. This means it earned more money on each share.
- It generated $10.6 billion in cash from its business during the first six months of 2026, compared with $7.6 billion in the same period of 2025. This shows that the company is generating more cash.
- It increased its 2026 adjusted EPS estimate to $7.90–$8.10, compared with its earlier estimate of $7.30–$7.50.
- It expects to make at least $414 billion in revenue in 2026. This shows that the company expects its sales to keep growing.
Bear Case:
- It had about $59.45 billion in long-term debt and $1.96 billion in current long-term debt as of June 30, 2026.
- The Health Care Benefits business had a medical benefit ratio of 87.4% in Q2 2026.
- It had 26.0 million medical members in June 2026, down from 26.7 million a year earlier.
- Pharmacy and Consumer Wellness revenue was $33.82 billion in Q2 2026, compared with $33.58 billion in Q2 2025.
Conclusion
It is a large healthcare company that runs pharmacies, health insurance, prescription services, and primary care businesses. Its business improved in 2026, with higher sales, profit, and cash flow. The company also expects to grow further. However, it faces risks from rising healthcare costs, pharmacy pressure, debt, and changes in healthcare rules. Overall, it has good growth opportunities, but investors should also consider these risks before investing.
